Clinical trials
Observational Coronary Disease trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 4 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Edinburgh | 5 |
| London School of Hygiene and Tropical Medicine | 4 |
| University College, London | 4 |
| Abbott Medical Devices | 2 |
| Boston Scientific Corporation | 2 |
| Cambridge University Hospitals NHS Foundation Trust | 2 |
| Imperial College London | 2 |
| Sheffield Hallam University | 2 |
| Bayer | 1 |
| Future Genetics Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Disease | 31 |
| Cardiovascular Diseases | 8 |
| Coronary Artery Disease | 7 |
| Myocardial Infarction | 6 |
| Angina Pectoris | 5 |
| Heart Failure | 5 |
| Hypertension | 4 |
| Myocardial Ischemia | 4 |
| Peripheral Arterial Disease | 4 |
| Diabetes Mellitus | 3 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.